Jinkai Zang

发表

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant

D. Lavillette, Chao Zhang, Qiuyue Liu, 2022, Frontiers in Immunology.

An mRNA vaccine candidate for the SARS-CoV-2 Omicron variant

D. Lavillette, Chao Zhang, Haikun Wang, 2022, bioRxiv.

Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines

D. Lavillette, Chao Zhang, Yong Yang, 2021, Viruses.

Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection

Chao Zhang, Yong Yang, Zhong Huang, 2021, Cell discovery.

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein

D. Lavillette, Chao Zhang, Yong Yang, 2021, Emerging microbes & infections.

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement

D. Qu, D. Lavillette, Chao Zhang, 2020, Cell Discovery.

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections

D. Qu, D. Lavillette, Chao Zhang, 2021, Nature communications.

H7N9 virulent mutants detected in chickens in China pose an increased threat to humans

Hualan Chen, G. Deng, G. Tian, 2017, Cell Research.

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections

D. Lavillette, Chao Zhang, Yong Yang, 2021, Nature Communications.

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement

D. Qu, D. Lavillette, Chao Zhang, 2020, Cell discovery.